Non-Coding RNAs in Hodgkin Lymphoma

被引:17
作者
Cordeiro, Anna [1 ]
Monzo, Mariano [1 ]
Navarro, Alfons [1 ]
机构
[1] Univ Barcelona, Sch Med, Human Anat & Embryol Unit, Mol Oncol & Embryol Lab, C Casanova 143, Barcelona 08032, Spain
关键词
Hodgkin lymphoma; non-coding RNAs; miRNAs; lncRNAs; piRNAs; REED-STERNBERG CELLS; MICRORNA EXPRESSION; DOWN-REGULATION; B-CELLS; MIR-155; BIOGENESIS; DIFFERENTIATION; PATHOGENESIS; CONTRIBUTES; METHYLATION;
D O I
10.3390/ijms18061154
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
MicroRNAs (miRNAs), small non-coding RNAs that regulate gene expression by binding to the 3'-UTR of their target genes, can act as oncogenes or tumor suppressors. Recently, other types of non-coding RNAs-piwiRNAs and long non-coding RNAs-have also been identified. Hodgkin lymphoma (HL) is a B cell origin disease characterized by the presence of only 1% of tumor cells, known as Hodgkin and Reed-Stenberg (HRS) cells, which interact with the microenvironment to evade apoptosis. Several studies have reported specific miRNA signatures that can differentiate HL lymph nodes from reactive lymph nodes, identify histologic groups within classical HL, and distinguish HRS cells from germinal center B cells. Moreover, some signatures are associated with survival or response to chemotherapy. Most of the miRNAs in the signatures regulate genes related to apoptosis, cell cycle arrest, or signaling pathways. Here we review findings on miRNAs in HL, as well as on other non-coding RNAs.
引用
收藏
页数:15
相关论文
共 72 条
[1]
[Anonymous], 2016, MED ONCOL
[2]
Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma [J].
Babar, Imran A. ;
Cheng, Christopher J. ;
Booth, Carmen J. ;
Liang, Xianping ;
Weidhaas, Joanne B. ;
Saltzman, W. Mark ;
Slack, Frank J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (26) :E1695-E1704
[3]
MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[4]
MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[5]
Germinal centres and B cell lymphomagenesis [J].
Basso, Katia ;
Dalla-Favera, Riccardo .
NATURE REVIEWS IMMUNOLOGY, 2015, 15 (03) :172-184
[6]
Investigation of miR9-1, miR9-2 and miR9-3 Methylation in Hodgkin Lymphoma [J].
Ben Dhiab, Myriam ;
Ziadi, Sonia ;
Louhichi, Teheni ;
Ben Gacem, Riadh ;
Ksiaa, Feryel ;
Trimeche, Mounir .
PATHOBIOLOGY, 2015, 82 (05) :195-202
[7]
The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications [J].
Campo, Elias ;
Swerdlow, Steven H. ;
Harris, Nancy L. ;
Pileri, Stefano ;
Stein, Harald ;
Jaffe, Elaine S. .
BLOOD, 2011, 117 (19) :5019-5032
[8]
piRNA, the new non-coding RNA, is aberrantly expressed in human cancer cells [J].
Cheng, Jia ;
Guo, Jun-Ming ;
Xiao, Bing-Xiu ;
Miao, Ying ;
Jiang, Zhen ;
Zhou, Hui ;
Li, Qing-Ning .
CLINICA CHIMICA ACTA, 2011, 412 (17-18) :1621-1625
[9]
PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma [J].
Cordeiro, Anna ;
Navarro, Alfons ;
Gaya, Anna ;
Diaz-Beya, Marina ;
Gonzalez-Farre, Blanca ;
Josep Castellano, Joan ;
Fuster, Dolors ;
Martinez, Carmen ;
Martinez, Antonio ;
Monzo, Mariano .
ONCOTARGET, 2016, 7 (29) :46002-46013
[10]
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice [J].
Costinean, S ;
Zanesi, N ;
Pekarsky, Y ;
Tili, E ;
Volinia, S ;
Heerema, N ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (18) :7024-7029